IP Library Granted Patent US 7,151,088
Granted Patent B2
US 7,151,088 · App. 11/230,503 · Granted Dec 19, 2006

Neuroprotective dietary supplement

Assignee: Ebewe Pharma Ges.M.H. Nfg.KG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,151,088
App. No.
11/230,503
Granted
Dec 19, 2006
Kind
B2
Abstract

The invention relates to a novel dietary supplement mixture having improved neuroprotective activity and preventing, ameliorating or counteracting neurodegeneration and preventing, counteracting and/or improving cognitive function decline. It also provides a dietary supplement, which is to be administered in an oral dosage form.

Claims (10)

1. A dietary supplement mixture having neuroprotective activity which comprises a peptide formulation, comprising a peptide having the amino acid sequence of ASAFQGIGSTHWVYDGVGNS (SEQ ID NO: 2).

2. The dietary supplement mixture according to claim 1 further comprising additional amino acids.

3. The dietary supplement mixture according to claim 1 further comprising peptides with a molecular weight less than 10 kDa.

4. The dietary supplement mixture according to claim 1 further comprising trace elements and/or mineral substance and/or vitamins and/or caffeine and/or taurine and/or fatty acids and/or phospholipids, and/or phosphatidylserines and/or plant extracts.

5. The dietary supplement mixture according to claim 1 further comprising acceptable additives and/or excipients and/or fillers and/or colouring substrates and/or flavouring substances.

6. An oral dosage form comprising a dietary supplement mixture according to claim 1 and acceptable additives and/or excipients and/or fillers and/or colouring substances and/or flavouring substances and/or solvents.

7. The oral dosage according to claim 6 , comprising 2–20 wt % peptides.

8. The oral dosage form according to claim 7 further comprising 10–30 wt % amino acids.

9. A method of treating age-associated memory impairment and/or age-associated cognitive decline and/or benign senescent forgetfulness, which comprises administering to a patient in need thereof an effective amount of the dietary supplement mixture according to claim 1 .

10. A method of supporting healthy mental function during the aging processes, which comprises administering to a patient in need thereof an effective amount of the dietary supplement mixture according to claim 1 .

Assignments (3)
CHANGE OF ADDRESS OF ASSIGNEE Recorded Jun 30, 2010
From: EVER NEURO PHARMA GMBH
To: EVER NEURO PHARMA GMBH
Reel/Frame 024611/0326 →
CHANGE OF NAME Recorded Jan 5, 2010
From: EBEWE NEURO PHARMA GMBH
To: EVER NEURO PHARMA GMBH
Reel/Frame 023768/0566 →
CHANGE OF NAME Recorded May 5, 2009
From: EBEWE PHARMA GES.M.B.H NFG KG
To: EBEWE NEURO PHARMA GMBH
Reel/Frame 022668/0036 →
Continuity (2)
Division 1076648000 · Jan 29, 2004
Related Publication 20060035812A1 · Feb 16, 2006